thioxanthone

01/01/1999 - "Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin."
02/01/2009 - "A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors."
08/01/2008 - "Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies."
08/05/2001 - "A simple and reliable HPLC method was developed for the estimation of a new anti-cancer agent that belongs to the thioxanthone class, SR271425 in mouse plasma. "
01/01/1999 - "SR233377 (WIN33377) is a novel 4-aminomethyl thioxanthone derivative with promising preclinical activity against solid tumors at doses substantially below the MTD. "

10/10/2016 - "Modulation of Autophagy by a Thioxanthone Decreases the Viability of Melanoma Cells."
10/10/2016 - "(1) Background: Our previous studies unveiled the hit thioxanthone TXA1 as an inhibitor of P-glycoprotein (drug efflux pump) and of human tumor cells growth, namely of melanoma cells. "

05/01/1964 - "[ELECTROCARDIOGRAPHIC CHANGES IN SCHISTOSOMIASIS PATIENTS SUBMITTING TO TREATMENT WITH A THIOXANTHONE DERIVATIVE]."
01/01/1960 - "& thioxanthone compounds in the treatment of schistosomiasis."
08/01/1951 - "[Preliminary note on the use of a thioxanthone derivative in the treatment of intestinal bilharziasis]."
09/01/1960 - "Synergism between antimony (tartar emetic) and thioxanthone compounds in the treatment of schistosomiasis."

01/01/2008 - "Novel photolabile protecting groups based on the 2-(2-nitrophenyl)propoxycarbonyl (NPPOC) group with a covalently linked thioxanthone as an intramolecular triplet sensitizer exhibit significantly enhanced light sensitivity under continuous illumination. "

10/31/1955 - "[Favorable therapeutic action of a derivative of thioxanthone (nilodin) in strongyloidiasis]."